日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma

肿瘤和免疫区室的纵向分析揭示了多发性骨髓瘤中失调模式及其与治疗反应的关联

Ohlstrom, Denis J; Pilcher, William C Jr; Michaud, Marina E; Acharya, Chaitanya; Satpathy, Sarthak; Gonzalez-Kozlova, Edgar; Jayasinghe, Reyka G; Ferguson, Katherine; Mumme, Hope L; Nanda, Shivani; Song, Yizhe; Mantrala, Sowmitri; Karagkouni, Dimitra; Schulman, Jessica; Pabustan, Nick; Vieira Dos Santos, Junia; Sherbenou, Daniel W; Keats, Jonathan J; Gout, Alexander M; Foltz, Steven; Lagana, Alessandro; Kourelis, Taxiarchis; Vij, Ravi; Dhodapkar, Madhav V; Avigan, David; Cho, Hearn Jay; Baughn, Linda B; Nooka, Ajay K; Lonial, Sagar; Kumar, Shaji; Samur, Mehmet K; Vlachos, Ioannis S; Ding, Li; Gnjatic, Sacha; Mulligan, George; Bhasin, Manoj K

ID2 Suppresses Multiple Myeloma Cell Proliferation by Repressing the Activity of the Transcription Factor TCF3.

ID2 通过抑制转录因子 TCF3 的活性来抑制多发性骨髓瘤细胞增殖。

Fulciniti Mariateresa, Yao Yao, Perini Tommaso, Fong Ng Jessica, Schavgoulidze Anaïs, Deng Shuhui, Cui Jian, Encinas Mayoral Jessica, Ladisa Francesco, Young Ryan M, Epstein Charles B, White Cassandra M, Ott Christopher J, Gulla Annamaria, Matulis Shannon M, Sperling Adam S, Morelli Eugenio, Boise Lawrence H, Binder Moritz, Szalat Raphael, Samur Mehmet K, Anderson Kenneth C, Munshi Nikhil C

Oridonin attenuates TLR4-driven inflammation and autophagy in LPS-stimulated enteric glial cells: an in vitro and in silico analysis

奥利多宁减弱LPS刺激的肠神经胶质细胞中TLR4驱动的炎症和自噬:一项体外和计算机模拟分析

Nemutlu Samur, Dilara; Boyacı, Aybüke; Maytalman, Erkan

Microsimulation model to identify suboptimal recurrence detection in patients with colorectal cancer following the current standard of care

利用微观模拟模型识别当前标准治疗方案下结直肠癌患者复发检测的不足之处

Samur, Sumeyye; Gursel, Emir; Gu, Ning Yan; Carter, Gebra Cuyun; Sahinkoc, Mert; Ayer, Turgay; Chhatwal, Jagpreet; Subramaniam, Somasundaram; Palomares, Melanie; Parikh, Aparna R; Neugut, Alfred I

ONCOllab for Transmission of Knowledge Related to Oral Complications of Cancer Therapy Among Dental Students

ONCOllab:面向牙科学生的癌症治疗口腔并发症相关知识传播项目

Samur Erguven, Sara; Friedlander, Paul L; Celik, Dilber; Ozkan, Aydin

Differential protein expression profiles in human sperm from teratozoospermic and normozoospermic men identify LTBP1 and TGF-βR1 as potential biomarkers within the TGF-β signalling pathway

畸形精子症患者和正常精子症患者精子中差异蛋白表达谱分析表明,LTBP1 和 TGF-βR1 是 TGF-β 信号通路中的潜在生物标志物。

Kaewman, Paweena; Nudmamud-Thanoi, Sutisa; Amatyakul, Patcharada; Punsawad, Chuchard; Roytrakul, Sittiruk; Thanoi, Samur

Development of hyperdiploidy starts at an early age and takes a decade to complete

超二倍体发育始于幼年时期,需要十年时间才能完成。

Samur, Mehmet K; Aktas Samur, Anil; Shah, Parth; Park, Joseph S; Fulciniti, Mariateresa; Shammas, Masood; Corre, Jill; Anderson, Kenneth C; Parmigiani, Giovanni; Avet-Loiseau, Hervé; Munshi, Nikhil C

Deciphering neutrophil dynamics in the focal lesion tumor microenvironment to overcome immunosuppression in multiple myeloma

解析局灶性病变肿瘤微环境中中性粒细胞的动态变化,以克服多发性骨髓瘤的免疫抑制

Rivera, Joshua; Yan, Qi; Daneshmandi, Saeed; Lannes, Romain; Katsuta, Eriko; Choi, JeeEun; Singh, Prashant; Belal, Ahmed; Alberico, Ronald; Lund, Ian; Schaefer, Megan; Hassan, Hamza; Parker, Sarah; Anderson, Kenneth C; Munshi, Nikhil C; Samur, Mehmet; McCarthy, Philip L; Hillengass, Jens; Mohammadpour, Hemn

Loss of BCL7A permits IRF4 transcriptional activity and cellular growth in multiple myeloma.

BCL7A 的缺失使得 IRF4 转录活性增强,并促进多发性骨髓瘤细胞的生长。

Chakraborty Chandraditya, Talluri Srikanth, Binder Moritz, Morelli Eugenio, Mayoral Jessica Encinas, Derebail Sanika, Samur Anil Aktas, Epstein Charles, Anderson Kenneth C, Shammas Masood, Samur Mehmet K, Fulciniti Mariateresa, Munshi Nikhil C

Immune profiling of smoldering multiple myeloma patients treated in a phase lb study of PVX-410 vaccine targeting XBP1/CD138/CS1 antigens, and citarinostat, a histone deacetylase inhibitor (HDACi) with and without lenalidomide

本研究对接受PVX-410疫苗(靶向XBP1/CD138/CS1抗原)和西他诺司他(一种组蛋白去乙酰化酶抑制剂,HDACi)联合或不联合来那度胺治疗的冒烟型多发性骨髓瘤患者进行了Ib期临床试验,并分析了接受西他诺司他治疗的冒烟型多发性骨髓瘤患者的免疫特征。

Cirstea, Diana; Shome, Rajib; Samur, Mehmet; Talluri, Srikanth; Connolly, Joseph J; Wright, Alexandra Jean; Duvallet, Emilie; Joyce, Amanda N R; Lively, Kathleen; Basinsky, Gina; Yee, Andrew J; Chase, Cristiana Costa; Malek, Ehsan; Niesvizky, Ruben; Richardson, Paul G; Raje, Noopur S